[Emerging pathologies and correlates of drug abuse in 2 therapeutic communities in Bergamo] NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Emerging pathologies and correlates of drug abuse in 2 therapeutic communities in Bergamo]

Boll Ist Sieroter Milan. 1986;65(6):544-51. Unique Identifier : AIDSLINE MED/87213690
Robba L; Carissoni ML; Goglio A; Scudeller G

Abstract: The authors monitored for 1 year 96 cases of ex-opiate addicts, belonging to two therapeutic Communities from Bergamo, a male and a female group, and a group of subjects living close to them (operators) or relatives and of laboratory technicians (51 cases on the whole). Protocols were set up with all the biochemical, hematological and serological parameters, to study the alterations connected with possible pathologies related to drug addiction, with repeated controls during the observation year. Only one LAS case was pointed out, at present markedly improved, a high incidence of hepatic involvement, due to previous hepatitis (type B or non A and non B), no alterations of kidney functions, while alterations of lymphocyte populations and subsets, thrombocytopenia, cross reactions with VDRL and negative TPHA, 45% of anti HTLV III antibody positive cases, were pointed out. Concerning the technicians and people living close to the examined subjects, no positivity for anti-HTLV III antibody, due to horizontal transmission of infection, was observed.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Adolescence Adult Antibodies, Viral/ANALYSIS English Abstract Female Follow-Up Studies Health Manpower Hepatitis B/IMMUNOLOGY Human Infant Italy Male Sexually Transmitted Diseases/IMMUNOLOGY Substance Abuse/*COMPLICATIONS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDimmunologyadolescenceadultantibodies,viral/analysisenglishabstractfemalefollow-upstudieshealthmanpowerhepatitisb/immunologyhumaninfantitalymalesexuallytransmitteddiseases/immunologysubstanceabuse/KWDcomplicationsjournalarticle
870930
M8790350

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .